Dépistage du cancer anal. Expérience d’une décennie de consultation spécialisée [Anal cancer screening. A decade's experience of a consultation in a tertiary centre]
Fiche du document
14 juin 2023
- doi: 10.53738/REVMED.2023.19.831.1186
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.831.1186
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37314258
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_944818F2A5481
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-12-14 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Carcinoma Cancers Malignancy (Cancer) Malignant tumorsCiter ce document
I. Espirito Santo et al., « Dépistage du cancer anal. Expérience d’une décennie de consultation spécialisée [Anal cancer screening. A decade's experience of a consultation in a tertiary centre] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.831.1186
Métriques
Partage / Export
Résumé
Anal cancer is a disease with a low but gradually increasing incidence, especially in developed countries. Most of these cancers are caused by the HPV. In Switzerland, more than 70 % of the sexually active population is infected with HPV at least once, making it the most common sexually transmitted disease. Immunosuppression and anal sex remain other major risk factors. Precancerous lesions can progress to anal cancer (up to 13 % at 5 years), hence the importance of early detection. High resolution anoscopy is the standard of care for diagnosis and primary treatment of lesions. It is therefore important to monitor at-risk groups and to proactively screen for gynaecological and anal HPV infection.